Statins Current Events | Statins News | 7
|
| Page
7 of
8 |
144 Results |
|
|
|
Sort By:
Page Views | Date |
Drug may reduce coronary artery plaque
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque. view more (2008-10-13)
Anti-fungal drug stops blood vessel growth
Researchers at Johns Hopkins have discovered to their surprise that a drug commonly used to treat toenail fungus can also block angiogenesis, the growth of new blood vessels commonly seen in cancers. view more (2007-04-30)
Preventive treatments in elderly people needs rethinking
Rather than prolonging life, preventive treatments in elderly people may simply change the cause of death - the manner of our dying, say doctors in this week's BMJ. view more (2007-08-10)
INEGY™ (Ezetimibe/Simvastatin) Receives First Approval in Europe
Merck & Co., Inc. and Schering-Plough Corporation today announced the regulatory approval of INEGY™ in Germany. INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or 'bad' cholesterol) through Dual Inhibition of both cholesterol production in the liver and absorption in the intestine. Germany is the first... view more... (2004-04-02)
Nicorandil Could Improve Outcome For Angina Patients
Results of a UK study in this week's issue of THE LANCET suggest that the antianginal drug nicorandil could reduce the risk of cardiovascular disease associated with angina. Angina occurs in 10% of men aged older than 60 years in the UK (10-15 years later in women), and is a common underlying cause of coronary heart disease (CHD). Aspirin,... view more... (2002-04-10)
Lowering cholesterol early in life could save lives
With heart disease maintaining top billing as the leading cause of death in the United States, a team of University of California, San Diego School of Medicine physician-researchers is proposing that aggressive intervention to lower cholesterol levels as early as childhood is the best approach available today to reducing the incidence of coronary... view more... (2008-08-05)
Cholesterol screening a cost-effective procedure to extend life in Hodgkin's disease survivors
Hodgkin's lymphoma survivors who have lipid screening every five years to detect high cholesterol will live a half year longer than patients who don't have the screening and the intervention is cost-effective. view more (2006-11-09)
International study launched testing new drug combination to cut cardiovascular disease
A major international study to test whether a new combination treatment that increases good "HDL" cholesterol prevents heart attacks and strokes will start to recruit patients later this year, it was announced today (Wednesday 31 May). view more (2006-05-31)
Statins Benefit Older People (pp 1618, 1623)
Elderly people at high risk of cardiovascular disease could benefit substantially by treatment with statins, cholesterol-lowering drugs with known effectiveness among middle-aged people at risk of heart disease and stroke, conclude authors of a study in this week's issue of THE LANCET. James Shepherd from the University of Glasgow, UK, and... view more... (2002-11-20)
ESC Congress 2004: Improvement of treatment for ST-elevation myocardial infarction in diabetics according to guidelines reduced hospital mortality in clinical practice by 36% between 1994 and 2002
Diabetes mellitus increases the risk to develop coronary artery disease by the factor two to four. Cardiovascular complications are the leading causes of morbidity and mortality in patients with diabetes. In randomized controlled trials as well as in prospective registries, diabetics with acute ST-elevation myocardial infarction (STEMI) have been... view more... (2004-08-30)
Cholesterol-lowering Drug May Also Reduce Risk of Blood Clots
Statin drugs, commonly used to lower high cholesterol blood levels, have been shown to possibly decrease the risk for thrombotic complications of antiphospholipid syndrome (APS), a disease associated with blood clotting and recurrent fetal loss. Research conducted on animal models, has shown success in using the drug fluvastatin to inhibit the... view more... (2004-11-10)
Unexpected finding of molecule's dual role in mice may open new avenue to cholesterol reduction
Researchers have discovered an unknown regulator of fat and cholesterol production in the liver of mice, a significant finding that could lead to new therapies for lowering unhealthy blood levels of cholesterol and fats. view more (2008-06-13)
University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
U of A medical researchers have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of Type 2 diabetes and heart disease related to obesity. view more (2008-01-10)
Impaired kidney function raises risk of heart problems in the elderly
A study published next week in the open access journal PLoS Medicine suggests that elderly people with damaged kidneys are at greater risk of cardiovascular disease, such as heart failure and stroke, and other causes of mortality. view more (2009-01-21)
Obese heart attack patients are more likely to survive after treatment than normal weight patients
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal. view more (2007-06-20)
Aspirin does not prevent heart attacks in patients with diabetes
Taking regular aspirin and antioxidant supplements does not prevent heart attacks even in high risk groups with diabetes and asymptomatic arterial disease, and aspirin should only be given to patients with established heart disease, stroke or limb arterial disease. view more (2008-10-17)
Risks of increased access to over-the-counter medicines may outweigh benefits
The risks of increasing people's access to over-the-counter medicines may outweigh the benefits, warn experts in this week's BMJ. view more (2008-03-28)
LDL particle measurement by NMR recognized by ADA, ACC
The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number by nuclear magnetic resonance (NMR) is one of the more accurate ways to evaluate cardiometabolic risk (CMR). view more (2008-03-31)
AGGRESSIVE LIPID-LOWERING THERAPY IS MORE EFFECTIVE IN REDUCING ATHEROSCLEROSIS (pp 574, 577)
The risk of atherosclerosis in people with high blood cholesterol could be reduced by aggressive lipid-lowering therapy, conclude authors of a study in this week's issue of THE LANCET. High LDL-cholesterol (the "bad" cholesterol) is a risk factor for atherosclerosis, which in turn is a risk factor for coronary artery disease (CAD). Tineke Smilde... view more... (2001-02-21)
Widely used cholesterol-lowering drug may prevent progression
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and... view more... (2009-10-30)
|
|
| Page
7 of
8 |
144 Results |
|
|
|
Sort By:
Page Views | Date |
|
